TY  - GEN
AU  - Chevaliez,Stéphane
AU  - Hézode,Christophe
AU  - Soulier,Alexandre
AU  - Costes,Bruno
AU  - Bouvier-Alias,Magali
AU  - Rouanet,Stéphanie
AU  - Foucher,Juliette
AU  - Bronowicki,Jean-Pierre
AU  - Tran,Albert
AU  - Rosa,Isabelle
AU  - Mathurin,Philippe
AU  - Alric,Laurent
AU  - Leroy,Vincent
AU  - Couzigou,Patrice
AU  - Mallat,Ariane
AU  - Charaf-Eddine,Mariem
AU  - Babany,Gérard
AU  - Pawlotsky,Jean-Michel
TI  - High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)
SN  - 1528-0012
PY  - 2011///0907
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Chi-Square Distribution
KW  - Drug Resistance, Viral
KW  - genetics
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - Hepatitis C, Chronic
KW  - diagnosis
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Interferons
KW  - Interleukins
KW  - Linear Models
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Phenotype
KW  - Polyethylene Glycols
KW  - RNA, Viral
KW  - blood
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - Viral Load
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1053/j.gastro.2011.03.039
ER  -